GLUCOSE 5% 50 g/1000 mL glucose injection bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glucose 5% 50 g/1000 ml glucose injection bag

fresenius kabi australia pty ltd - glucose, quantity: 50 g - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

VIAFLO 5% GLUCOSE 12.5g/250mL injection bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

viaflo 5% glucose 12.5g/250ml injection bag

baxter healthcare pty ltd - glucose, quantity: 50 g/l - injection, solution - excipient ingredients: water for injections - isotonic (glucose 5%) intravenous infusions are mainly indicated: ? whenever non-electrolyte fluid replacement is required. ? as a vehicle for drug delivery, provided that the added components are compatible with glucose.

GLUCOSE 10% 50g/500mL injection bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glucose 10% 50g/500ml injection bag

fresenius kabi australia pty ltd - glucose, quantity: 50 g - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

GLUCOSE 5% 25 g/500 mL glucose injection bag Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glucose 5% 25 g/500 ml glucose injection bag

fresenius kabi australia pty ltd - glucose, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in energy levels. glucose 5% is also used to correct hydration levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established.

Pfizer (Australia) GLUCOSE INTRAVENOUS INFUSION BP 5% glucose (as monohydrate) 5g/100 mL injection for infusion vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

pfizer (australia) glucose intravenous infusion bp 5% glucose (as monohydrate) 5g/100 ml injection for infusion vial

pfizer australia pty ltd - glucose monohydrate, quantity: 54.99 mg/ml (equivalent: glucose, qty 50 mg/ml) - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 31 july 2000: for fluid and carbohydrate depletion wherever a non-electrolyte fluid is required. in the treatment of hypoglycaemia. in the treatment of acute diarrhoeal disease. as a vehicle for the administration of other medications.

ASTRAZENECA GLUCOSE 5% 5g/100mL injection BP vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

astrazeneca glucose 5% 5g/100ml injection bp vial

phebra pty ltd - glucose, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium bicarbonate; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 4 april 2003: glucose injection bp 5% is used in the treatment of carbohydrate and fluid depletion. glucose is the preferred source of carbohydrate in parenteral nutrition regimes, and is used in the treatment of dehydration due to acute diarrhoeal disease. glucose injection bp 5% may also be used to treat hypoglycaemia.

PHEBRA GLUCOSE 50% intravenous infusion 25g/50mL vial Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra glucose 50% intravenous infusion 25g/50ml vial

phebra pty ltd - glucose, quantity: 500 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium bicarbonate - glucose 50% intravenous infusion is strongly hypertonic and may be used to reduce increased cerebrospinal pressure and/or oedema due to delirium tremens or acute alcoholic intoxication. it may also be used to treat severe hypoglycaemia due to an excess of insulin and to provide concentrated calories in total parenteral nutrition regimes.

Baxter 0.45% Sodium Chloride and 5% Glucose Intravenous Infusion 1000 mL bag (AHB6028) Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 5% glucose intravenous infusion 1000 ml bag (ahb6028)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections; hydrochloric acid - sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 25% GLUCOSE 250mg/L injection AHB0224 Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

baxter 25% glucose 250mg/l injection ahb0224

baxter healthcare pty ltd - glucose, quantity: 250 g/l - injection, solution - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

GLUCOSE 50 % Israel - anglès - Ministry of Health

glucose 50 %

lapidot medical import and marketing ltd - glucose as monohydrate - concentrate for solution for infusion - glucose as monohydrate 50 % - glucose - glucose - high caloric carbohydrate infusion hypoglycaemia.